The Recall Desk
SevereFDA (Drugs)·D-1379-2020·Announced 2020-07-15

EMD Serono Recalls Cetrotide Vials Due to Missing Rubber Stoppers

EMD Serono is recalling 30,756 vials of Cetrotide because missing rubber stoppers could compromise sterility assurance.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The FDA classifies this as a Class II recall. Per the rubric, an FDA Class II recall involving a significant risk to sterility assurance (potential infection) is classified as Severe.

Plain-English summary

EMD Serono, Inc. is recalling 30,756 vials of Cetrotide (cetrorelix acetate for Injection) 0.25 mg. The product is a sterile, prescription-only medication intended for subcutaneous use only. The recall covers Lot # 8J025A and 8J025B, which have an expiration date of 09/30/2020.

The recall was initiated due to market complaints regarding missing rubber stoppers on the drug vials. The FDA classifies this as a Class II recall because the missing stoppers could lead to a lack of sterility assurance. The affected product was distributed nationwide in the US.

Patients and healthcare providers should stop using the affected vials and contact EMD Serono, Inc. for further instructions or a replacement.

The recalled product

Product
CETROTIDE (CETRORELIX ACETATE)
Brand
CETROTIDE
Manufacturer
EMD Serono, Inc.
Affected units
30,756

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot # 8J025A
  • 8J025B
  • Exp 09/30/2020

Distribution

Distributed nationwide across the United States.

Same manufacturer · EMD Serono, Inc.

See all →